arrow
S

Stefania Cuzzubbo

universite paris cite
H指数:39
被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Plasma proteomics for prognostic stratification in newly diagnosed primary central nervous system lymphoma

血浆蛋白质组学在 newly diagnosed primary central nervous system lymphoma 患者预后分层中的应用

2026-09-230
PRE
CONDITIONAL SURVIVAL ANALYSIS IN IDH-MUTANT HIGH-GRADE GLIOMAS: AN USEFUL TOOL IN CLINICAL PRACTICE

IDH突变型高级别胶质瘤中的条件生存分析:临床实践中的有用工具

2025-11-010
OAAI
CONDITIONAL SURVIVAL ANALYSIS IN IDH-MUTANT HIGH-GRADE GLIOMAS: AN USEFUL TOOL IN CLINICAL PRACTICE

IDH突变型高级别胶质瘤中的条件生存分析:临床实践中的有用工具

2025-10-010
OAAI
A PHASE II STUDY OF AN ANTI-TERT VACCINE (UCPVAX) WITH OR WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA

一项针对新诊断胶质母细胞瘤的II期研究,研究一种抗TERT疫苗(UCPVAX),单独使用或与替莫唑胺联用。

2025-10-010
OAAI
DECIPHERING GLIOBLASTOMA METABOLIC SIGNATURE: MOLECULAR PROFILING AND NADH-FLIM IMAGING

解析胶质母细胞瘤代谢特征:分子谱分析与NADH-FLIM成像

2025-10-010
OAAI
UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM
2023-09-080
OA
OVERALL SURVIVAL ASSOCIATED WITH FIRST-LINE PCV OR TEMOZOLOMIDE IN COMBINATION WITH RADIOTHERAPY IN PATIENTS WITH IDH-MUTANT, 1P/19Q CODELETED, GRADE 3 OLIGODENDROGLIOMA: ANALYSIS FROM THE POLA COHORT
2023-09-081
OA